Home / Inspections / 1082467

FDA Inspection 1082467 — Joslin Diabetes Center Committee on Human Studies

Joslin Diabetes Center Committee on Human Studies — FEI 1283624

The FDA completed an inspection of Joslin Diabetes Center Committee on Human Studies on November 27, 2018 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 27, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

IRB

Facility

Other inspections at this facility

  • 1324384 (NAI Fri May 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 885331 (VAI Fri Jun 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 621686 (VAI Fri Oct 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources